Apoptotic deregulation of endothelial cells and intimal proliferation in pulmonary hypertension of congenital heart disease;Dysrégulation apoptotique des cellules endothélials et prolifération intimale dans l'hypertension artériole pulmonaire des cardiopathies congénitales

Archives des Maladies du Coeur et des Vaisseaux

Volumn 100, Issue 5, 2007, Pages 365-372

  Lévy, Marilyne ^b,c   Raisky, O ^b   Vouhe, P R ^b   Celermajer, D S ^c   Bonnet, D ^b   Lsrael Biet D ^a,d  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c University of Sydney   (Australia)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG BIOPSY; MALE; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; T LYMPHOCYTE;

ADOLESCENT; ADULT; ANTIGENS, CD34; APOPTOSIS; BIOLOGICAL MARKERS; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; INFANT; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; PROTO-ONCOGENE PROTEINS C-BCL-2; T-LYMPHOCYTES; TUNICA INTIMA; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34347369805     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Rabinovitch M, Haworth SG, Castaneda AR, Nadas AS, Reid LM. Lung biopsy in congenital heart disease : a morphometric approach to pulmonary vascular disease. Circulation 1978 ; 58: 1107-22.
2. Haworth SG, Reid L. A morphometric study of regional variation in lung structure in infants with pulmonary hypertension and congenital cardiac defect. A justification of lung biopsy. Br Heart J 1978 ; 40 : 825-31.
3. Vongpatanasin W, Brickner ME, Hillis LD, Lange RA. The Eisenmenger syndrome in adults. Ann Intern Med 1998 ; 128 : 745-55.
4. Stier S, Totzke G, Gruewald E, Neuhaus T, Fronhoffs S, Schoneborn S, Vetter H, Ko Y. Identification of p54 (nrb) and the 14-3-3 Protein HS1 as TNF-alpha-inducible genes related to cell cycle control and apoptosis in human arterial endothelial cells. J Biochem Mol Biol 2005 ; 38 : 447-56.
5. Sakao S, Taraseviciene-Stewart L, Lee JD, Wood K, Cool CD, Voelkel NF. Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells. FASEB J 2005 ; 19: 1178-80.
6. Matter CM, Chadjichristos CE, Meier P, et al. Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation. Circulation 2006 ; 113 : 1879-87.
7. Celermajer DS, Cullen S, Deanfield JE. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation 1993 ; 87 : 440-6.
8. Dinh Xuan AT, Higenbottam TW, Clelland C, Pepke-Zaba J, Cremona G, Wallwork J. Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome. Br J Pharmacol 1990 ; 99 : 9-10.
9. Haworth SG, Hislop AA. Pulmonary vascular development : normal values of peripheral vascular structure. Am J Cardiol 1983; 52 : 578-83.
10. Kuwano K, Hagimoto N, Tanaka T, et al. Expression of apoptosis-regulatory genes in epithelial cells in pulmonary fibrosis in mice. J Pathol 2000 ; 190 : 221-9.
11. Levy M, Maurey C, Chailley-Heu B, Martinovic J, Jaubert F, Israel-Biet D. Developmental changes in endothelial vasoactive and angiogenic growth factors in the human perinatal lung. Pediatr Res 2005 ; 57 : 248-53.
12. Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension. Circulation 2004 ; 109 : 159-65.
13. McMurtry MS, Archer SL, Altieri DC, et al. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J Clin Invest 2005; 115: 1479-91.
14. Takahashi H, Goto N, Kojima Y, et al. Downregulation of type II bone morpnogenetic protein receptor in hypoxic pulmonary hypertension. Am J Physiol 2006 ; 290 : L450-8.
15. Dorfmuller P, Perros F, Balabanian K, Humbert M. Inflammation in pulmonary arterial hypertension. Eur Respir J 2003 ; 22 : 358-63.
16. Humbert M, Morrell NW, Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004 ; 43 : 13S-24S.
17. Rabinovitch M. Pulmonary hypertension : pathophysiology as a basis for clinical decision making. J Heart Lung Transplant 1999; 18: 1041-53.
18. Teichert-Kuliszewska K, Kutryk MJ, Kuliszewski MA, et al. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival : implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ Res 2006 ; 98 : 209-17.
19. Taraseviciene-Stewart L, Scerbavicius R, Choe KH, et al. Simvastatin Causes Endothelial Cell Apoptosis and Attenuates Severe Pulmonary Hypertension. Am J Physiol Lung Cell Mol Physiol. 2006 ; 291 : L668-76 May.
20. Roy H, Bhardwaj S, Yla-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett 2006 ; 580 : 2879-87.
21. Yu J, deMuinck ED, Zhuang Z, et al. Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc Natl Acad Sci USA 2005 ; 102: 10999-1004.
22. Cai J, Jiang WG, Ahmed A, Boulton M. Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS. Microvasc Res 2006 ; 71 : 20-31.
23. Kawasaki K, Smith RS Jr, Hsieh CM, Sun J, Chao J, Liao JK. Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis. Mol Cell Biol 2003 ; 23 : 5726-37.
24. Berger RM, Geiger R, Hess J, Bogers AJ, Mooi WJ. Altered arterial expression patterns of inducible and endothelial nitric oxide synthase in pulmonary plexogenic arteriopathy caused by congenital heart disease. Am J Respir Crit Care Med 2001 ; 163: 1493-9.
25. Mason NA, Springall DR, Burke M, et al. High expression of endothelial nitric oxide synthase in plexiform lesions of pulmonary hypertension. J Pathol 1998 ; 185 : 313-8.
26. Lam CF, Peterson TE, Croatt AJ, Nath KA, Katusic ZS. Functionnal adaptation and remodeling of pulmonary artery in flow-induced pulmonary hypertension. Am J Physiol 2005 ; 289 : H2334-41.
27. Black SM, Fineman JR, Steinhorn RH, Bristow J, Soifer SJ. Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol 1998 ; 275: H1643-51.
28. Xia Y, Tsai AL, Berka V, Zweier JL. Superoxide generation from endothelial nitric-oxide synthase. A Ca2 +/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem 1998 ; 273 : 25804-8.
29. Tuder RM, Chacon M, Alger L, et al. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension : evidence for a process of disordered angiogenesis. J Pathol 2001 ; 195 : 367-74.
30. Grosjean J, Kiriakidis S, Reilly K, Feldmann M, Paleolog E. Vascular endothelial growth factor signalling in endothelial cell survival : A role for NFkappaB. Biochem Biophys Res Commun 2006 ; 340 : 984-94.